NSAID stimulation of human cartilage matrix synthesis. A study of the mechanism of action of aceclofenac

Clinical Drug Investigation

Volumn 14, Issue 5, 1997, Pages 353-362

  Dingle, J T ^a,b   Parker, M ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; GLYCOSAMINOGLYCAN; GROWTH FACTOR; IBUPROFEN; INDOMETACIN; INTERLEUKIN 1; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SOMATOMEDIN C; TENIDAP;

ADULT; AGED; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CLASSIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; PRIORITY JOURNAL; STIMULATION; SYNTHESIS; TOXICITY;

EID: 0030664687     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714050-00003     Document Type: Article

References (31)

1. Dingle JT. Cartilage maintenance in osteoarthritis: interactions of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheum 1991; 18 Suppl. 28: 30-7
2. Dingle JT. Cartilage damage and repair: the roles of IL1, NSAIDs and prostaglandins in osteoarthritis. In: New frontiers in prostaglandin therapeutics. Princetown, USA: Excerpa Medica, 1990: 1-15
3. Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 1989; 260: 543-8
4. Dingle JT. Prostaglandins in human cartilage metabolism. J Lipid Medial 1993; 6: 303-12
5. Verbruggen G, Veys EM, Malfait A, et al. Proteoglycan metabolism in tissue cultured human articular cartilage: influence of piroxicam. J Rheumatol 1989; 16 (3): 355-61
6. Rashad S, Revell P, Hemingway A, et al. Effect of non-steroid anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 11: 519-22
7. Huskisson EC, Berry H, Gishen P, et al. On behalf of the LINK Study group. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941-6
8. McKenzie LS, Horsburgh BA, Ghosh P, et al. Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage. Ann Rheum Dis 1976; 35: 487-95
9. Brandt KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 1987; 83 (5A): 29-34
10. Willbrink B, Van der Veen MJ, Huber H, et al. In vitro influence of ketoprofen on proteoglycan metabolism of human normal and osteoarthritic cartilage. Agents Actions 1991; 32 (2/4): 154-9
11. Roy WS. The metabolism of normal and osteoarthritic human articular cartilage and the effect of NSAID on this metabolism. MPhil Thesis, 1994: Cambridge
12. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vitro effect of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage. J Rheumatol 1989; 165: 646-55
13. Dingle JT. The effect of NSAIDs in human articular cartilage GAG synthesis. Eur J Rheumatol Inflamm 1996; 16: 47-52
14. Gonzalez E, De La Cruz C, de Nicolas R, et al. Long term effects of NSAID on the production of cytokines and other inflammatory mediators by blood cells of patients with OA. Agents Actions 1994; 41: 171-8
15. Dingle JT, Saklatvala J, Hembry R, et al. A cartilage catabolic factor from synovium. Biochem J 1979; 184: 177-80
16. Saklatvala J, Sarsfield SJ, How do IL-1 and TNF induce degradation of proteoglycan in cartilages. In: Glauert AM, editor. The control of tissue damage. Amsterdam: Elsevier, 1988: 97-106
17. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-15
18. Barrett AJ, Saklalvala J. Proteinases in joint disease. In: Kelly WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. 2nd ed. Philadelphia: WB Saunders, 1985: 182-96
19. Buttle DJ, Saklatvala J, Tamai M, et al. Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidase. Biochem J 1991; 280: 175-7
20. Martel-Pelletier J, McCollum R, Fujimoto N, et al. Excess of metalloproteases over tissue inhibitor or metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994; 70: 807-15
21. Shield MJ. Misoprostol: New Frontiers; benefits beyond the gastrointestinal tract. Scand J Rheumatol 1992; Suppl. 92: 31-52
22. Dingle JT, Horner A, Shield M. The sensitivity of synthesis of human cartilage matrix to inhibition by IL1 suggests a mechanism for the development of osteoarthritis. Cell Biochem Funct 1991; 9: 99-102
23. Dingle JT, Fell HB, Lucy JA. Synthesis of connective tissue components. The effect of retinol and hydrocortisone on cultured limb-bone rudiments. Biochem J 1996; 98: 173-81
24. Dingle JT. Heberden Oration 1978. Recent studies on the control of joint damage: the contribution of the Strangeways Research Laboratory. Ann Rheum Dis 1979; 38: 201-14
25. Dingle JT. The use of cytokines and NSAIDs in osteoarthritis; the use of human cartilage in drug assessment. Eur J Rheumatol Inflammation 1992; 12: 3-8
26. Dingle JT, Parker M. Chondroprotection and the role of NSAID: a study of human cartilage metabolism. Brazil J Rheum 1997; 37: 37-46
27. Pelletier JP, Cloutier JM, Martel-Pelletier J. Evidence for involvement of IL1 in OA cartilage degradation: protective effect of NSAID. J Rheumatol 1989; 16 Suppl. 18: 19-27
28. Cawston TE. Metalloproteinases and connective tissue breakdown. Rheumatol Rev 1994; 3: 147-54
29. Arend WP, Dayer JM. Naturally occurring inhibitors of cytokines in immunopharmacology of joints and connective tissue. In: Davies EM, Dingle JT, editors. London: Academic Press, 1994: 129-49
30. Bort R, Ponsoda X, Carrases E, et al. Comparative metabolism of the NSAID aceclofenac in the rat, monkey and man. Drug Metabolism 1997. In press
31. Dingle JT, Page Thomas DP, King B, et al. In vivo studies of articular tissue damage mediated by catabolin/interleukin I. Ann Rheum Dis 1987; 46: 527-33